Thalidomide resistance is based on the capacity of the glutathione-dependent antioxidant defense.

Thalidomide as an effective treatment for multiple myeloma and leprosy has also caused birth defects in thousands of children five decades ago particularly in Europe. Thus its use in humans remains limited. The rapid and fatal approval of thalidomide at that time ultimately was a consequence of the sole use of thalidomide-insensitive species in animal toxicity tests. Here, we aimed at elucidating the molecular basis for the resistance of mice to thalidomide teratogenicity. By using hydroethidine staining we demonstrate that thalidomide induces the formation of superoxide in embryonic fibroblasts of thalidomide-sensitive species but not in those of mice. As determined by trypan blue staining, scavenging of superoxide prevents thalidomide-induced apoptosis, a marker for thalidomide teratogenicity. Mouse embryonic fibroblasts are found to have higher glutathione levels than those of sensitive species and can be sensitized for thalidomide by glutathione depletion with diethyl maleate or diamide. Accordingly, experimental increase of glutathione levels in human embryonic fibroblasts by adding N-acetyl cysteine or glutathione ethyl ester to the culture medium counteracts thalidomide-induced apoptosis. Finally, we show that thalidomide-induced molecular pathology downstream of superoxide is essentially identical in human and sensitized mouse embryonic fibroblasts. In conclusion, thalidomide-resistance is based on the capacity of the glutathione-dependent antioxidant defense. We provide a basis to pharmacologically overcome the limitations of thalidomide use at humans and describe substantial differences between human and mouse embryonic cells regarding the protection against oxidative stress.

[1]  K. Schulze-Osthoff,et al.  Thalidomide Induces Limb Anomalies by PTEN Stabilization, Akt Suppression, and Stimulation of Caspase-Dependent Cell Death , 2012, Molecular and Cellular Biology.

[2]  J. Knobloch,et al.  Shedding light on an old mystery: Thalidomide suppresses survival pathways to induce limb defects , 2008, Cell cycle.

[3]  K. Chin,et al.  Gene Expression (1086 articles) , 2006 .

[4]  D. Harrison,et al.  Reactive oxygen species-selective regulation of aortic inflammatory gene expression in Type 2 diabetes. , 2007, American journal of physiology. Heart and circulatory physiology.

[5]  J. Shaughnessy,et al.  Thalidomide induces limb deformities by perturbing the Bmp/Dkkl/Wnt signaling pathway , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  D. Hernández-García,et al.  Expression and regulation of antioxidant enzymes in the developing limb support a function of ROS in interdigital cell death. , 2006, Developmental biology.

[7]  P. G. Wells,et al.  Molecular and biochemical mechanisms in teratogenesis involving reactive oxygen species. , 2005, Toxicology and applied pharmacology.

[8]  J. Zeldis,et al.  Thalidomide as a novel therapeutic agent: new uses for an old product. , 2005, Drug discovery today.

[9]  U. Ruegg,et al.  Role of superoxide as a signaling molecule. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[10]  C. Harris,et al.  A novel hypothesis for thalidomide-induced limb teratogenesis: redox misregulation of the NF-kappaB pathway. , 2004, Antioxidants & redox signaling.

[11]  E. Schwarz,et al.  Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFkappaB. , 2002, Biochemical and biophysical research communications.

[12]  U. Rüther,et al.  The Wnt antagonist Dickkopf‐1 is regulated by Bmp signaling and c‐Jun and modulates programmed cell death , 2002, The EMBO journal.

[13]  S. Catarzi,et al.  GSH role on platelet-derived growth factor receptor tyrosine phosphorylation induced by H2O2. , 2001, Biochemical and biophysical research communications.

[14]  P. G. Wells,et al.  Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity , 1999, Nature Medicine.

[15]  J. Marshall,et al.  Thiol-mediated redox regulation of neutrophil apoptosis. , 1996, Surgery.

[16]  R. E. Staples,et al.  Assessment of the effectiveness of animal developmental toxicity testing for human safety. , 1993, Reproductive toxicology.

[17]  W. Lenz A short history of thalidomide embryopathy. , 1988, Teratology.